CUV 1.61% $14.68 clinuvel pharmaceuticals limited

Ann: Positive Final Results in Stroke Study CUV801, page-15

  1. 742 Posts.
    lightbulb Created with Sketch. 206
    I think a buyback would stabilise the price but probably not going to lift it a great deal at these sorts of levels. Shares on issue is not really an issue (only 50 million odd) but in fact the limited liquidity doesn't help the volatility hence reducing the shares on issue won't achieve much there. Doesn't seem to be on the company radar at this point. Anything would be nice though to give some impetus. GLTA
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.